$JOBY Balance Sheet | Understand Stock

$JOBY

$5.02 +$0.33 (6.93%) Live

$JOBY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Total cash, cash equivalents and short-term investments
Restricted cash
Accounts and other receivables
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Restricted cash
Equity method investment
Intangible assets
Goodwill
Other non-current assets
Total assets

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Tenant improvements loan, current portion
Capital lease, current portion
Deferred rent, current portion
Operating lease liabilities, current portion
Accrued expenses and other current liabilities
Total current liabilities

Tenant improvements loan, net of current portion
Capital lease, net of current portion
Deferred rent, net of current portion
Operating lease liabilities, net of current portion
Stock repurchase liability
Long-term debt
Warrant liability
Earnout shares liability
Other non-current liabilities
Total liabilities
Redeemable convertible preferred stock: $0.00001 par value - 100,000,000 and 364,736,031 shares authorized at December 31, 2021 and 2020, no shares and 332,764,215 shares issued and outstanding at December 31, 2021 and 2020, respectively (Cumulative liquidation preference $769,679 at December 31, 2020)
Stockholders’ equity:
Preferred stock: $0.0001 par value - 100,000,000 shares authorized. No shares issued and outstanding.
Common stock: $0.0001 par value - 2,800,000,000 shares authorized; 986,521,249 and 915,076,698 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total stockholders’ equity
Total liabilities and stockholders’ equity

Common stock, shares authorized (in shares)

Comments